Markus P. WEIGL, Jürgen FRICK, Thomas BROCK, Branislav ZAGRAPAN, Stefan DIRNHOFER, Ingmar KÖNIGSRAINER, Peter TSCHANN
{"title":"Primary splenic carcinosarcoma: case report of a rare finding and review of the literature","authors":"Markus P. WEIGL, Jürgen FRICK, Thomas BROCK, Branislav ZAGRAPAN, Stefan DIRNHOFER, Ingmar KÖNIGSRAINER, Peter TSCHANN","doi":"10.23736/s0394-9508.22.05490-0","DOIUrl":null,"url":null,"abstract":"Primary carcinosarcomas of the spleen are extremely rare malignancies with a poor prognosis. Their pathogenesis is not fully understood and guidelines concerning their diagnosis, or their therapy do not exist. A 55-year-old woman was admitted to our department with chronic pain in the upper left abdomen and a CT-validated mass in the spleen. After a splenectomy without complication, an extensive histopathological examination was conducted revealing a primary carcinosarcoma of the spleen. Further imaging was carried out to exclude a different origin of the tumor. Interdisciplinary discussion agreed upon an adjuvant chemotherapy. Eight months after surgery no signs of recurrence are present, and the patient reports no recurring symptoms. Splenic carcinosarcomas are unusual and bear a high potency for metastasis and a limited overall survival. The primary therapy is surgical removal with no general agreement concerning adjuvant chemotherapy. Further discussions relating to different therapy options are needed to provide sufficient care for affected patients.","PeriodicalId":10171,"journal":{"name":"Chirurgia","volume":"20 2","pages":"0"},"PeriodicalIF":0.8000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chirurgia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s0394-9508.22.05490-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Primary carcinosarcomas of the spleen are extremely rare malignancies with a poor prognosis. Their pathogenesis is not fully understood and guidelines concerning their diagnosis, or their therapy do not exist. A 55-year-old woman was admitted to our department with chronic pain in the upper left abdomen and a CT-validated mass in the spleen. After a splenectomy without complication, an extensive histopathological examination was conducted revealing a primary carcinosarcoma of the spleen. Further imaging was carried out to exclude a different origin of the tumor. Interdisciplinary discussion agreed upon an adjuvant chemotherapy. Eight months after surgery no signs of recurrence are present, and the patient reports no recurring symptoms. Splenic carcinosarcomas are unusual and bear a high potency for metastasis and a limited overall survival. The primary therapy is surgical removal with no general agreement concerning adjuvant chemotherapy. Further discussions relating to different therapy options are needed to provide sufficient care for affected patients.
期刊介绍:
Chirurgia is a bimonthly journal. In Chirurgia, original papers in the area of general surgery which neither
appeared, nor were sent for publication in other periodicals, can be published. You can send original articles,
new surgical techniques, or comprehensive general reports on surgical topics, clinical case presentations and,
depending on publication space, - reviews of some articles of general interest to surgeons from other publications.
Chirurgia is also a place for sharing information about the activity of various branches of the Romanian Society of
Surgery, information on Congresses and Symposiums organized by the Romanian Society of Surgery and
participation notes in other scientific meetings.
Letters to the editor: Letters commenting on papers published in Chirurgia are welcomed. They should contain
substantive ideas and commentaries supported by appropriate data, and should not exceed 2 pages. Please
submit these letters to the editor through our online system.